Gri BioGRI
13F holders, Q2 2025 (June 30)5holders
0new positions
0sold out
$1.29avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Gri Bio Inc. (GRI) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were UBS Group AG ($20K), Tower Research Capital LLC (TRC) ($5K) and BlackRock, Inc. ($272).
- Company
- Gri Bio Inc.
- CUSIP
- 3622AW403
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 14,786 shares bought, net +14,786 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UBS Group AG | 0.00% | Add +376.3% | 15,455 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +201.2% | 3,834 | $5K |
| BlackRock, Inc. | 0.00% | No change | 211 | $272 |
| SBI Securities Co., Ltd. | 0.00% | No change | 117 | $151 |
| Bank of America Corp. | 0.00% | Add +375.0% | 19 | $25 |
"% of holder's portfolio" is GRI's weight in each manager's 13F, not the share of Gri Bio Inc. the manager owns.